Who backs Treeline Biosciences?
14 investors| Investor | Type |
|---|---|
| GV | Venture capital |
| OrbiMed | Growth equity |
| ARCH Venture Partners | Venture capital |
| T. Rowe Price Group | — |
| Fidelity | — |
| Casdin Capital | Venture capital |
| Arc Ventures (United States) | — |
| Rock Springs Capital | Hedge fund |
| Access Industries | Other |
| Aisling Capital | Venture capital |
| + 4 more investors · a free account shows the complete list | |
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns
Membership and data by Private Market View
Treeline Biosciences investors
14 investors are on record for Treeline Biosciences, including GV, OrbiMed, ARCH Venture Partners and T. Rowe Price Group. By type, the record holds 4 venture capital firms, 1 hedge fund and 1 growth equity firm. The later-stage round in Aug 2025 drew 22 investors.
Free account
More of Treeline Biosciences with a free account
- ·The complete investor list: 14 names
- ·Watch Treeline Biosciences: the Monday email on marks, rounds and moves
For fundraisers
Work this list, don’t just read it
These 14 firms already write checks for companies like Treeline Biosciences. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.
Membership and data by Private Market View